MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma |
Baylor College of Medicine / Lingzhi Li, PhD |
Young Investigator Grants |
2024 |
Texas |
Capitalizing on functional genomics with targeted protein degradation in neuroblastoma |
St. Jude Children’s Research Hospital / Ian Delahunty, PhD |
Young Investigator Grants |
2024 |
Tennessee |
Modifying CAR T cell epigenetic programs to improve therapy against aggressive pediatric brain tumors |
St. Jude Children’s Research Hospital / Meghan Ward, PhD |
Young Investigator Grants |
2024 |
Tennessee |
Exploiting a Novel DNA Repair Defect in Ewing Sarcoma |
Dana-Farber Cancer Institute / Shuhei Asada, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
The influence of the raphe nucleus and serotonin on progression of diffuse intrinsic pontine glioma |
Stanford University / Richard Drexler, MD/PhD |
Young Investigator Grants |
2024 |
California |
Improving homing and activity of CAR T cells in pediatric sarcomas |
University of Colorado Denver / Joselyn Cruz Cruz, PhD |
Young Investigator Grants |
2024 |
Colorado |
Defining how unique properties of the pediatric immune system contribute to poor efficacy of checkpoint blockade in children |
Stanford University / Adrienne Long, MD/PhD |
Young Investigator Grants |
2024 |
California |
Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma |
University of Colorado Denver / Dong Wang, PhD |
Young Investigator Grants |
2024 |
Colorado |
Novel mechanisms and therapeutic targeting of chemoresistant rhabdomyosarcoma |
Massachusetts General Hospital / Yueyang Wang, PhD |
Young Investigator Grants |
2024 |
Massachusetts |